Systematically Prognostic Analyses of Gastric Cancer Patients with Ovarian Metastasis

被引:1
|
作者
Peng, Peng [1 ]
Liu, Xiuyuan [1 ]
Yang, Lin [1 ]
Gu, Zhenguang [1 ]
Cai, Lin [2 ]
机构
[1] Xuzhou Kuangshan Hosp, Dept Gen Surg, Xuzhou, Peoples R China
[2] Xuzhou Polytech Coll Bioengn, Sch Food & Drug, Xuzhou, Peoples R China
关键词
KRUKENBERG TUMOR;
D O I
10.1155/2023/9923428
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ovarian metastasis of gastric cancer indicates that the disease has reached the late stage and the opportunity for radical surgery is restricted. However, the clinical characteristics and prognosis of patients with gastric cancer ovarian metastasis (GCOM) remain to be illustrated. Here, we retrieved the information of 780 GCOM cases from the Surveillance, Epidemiology, and End Results (SEERs) database and analyzed their clinicopathological characteristics as well as their survival. According to our data, most GCOM patients showed poor pathological differentiation, advanced T and N stages. The prognostic factors include patients' age, tumor size, surgical resection, and chemotherapy treatment. Of note, the marriage status was also identified as an independent prognostic factor. Besides the identification of prognostic factors, we established nomograms to help predict the overall survival and cancer-specific survival of GCOM, respectively.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Gastric Metastasis From a Primary Ovarian Cancer
    Nathani, Komal G.
    Zamir, Asif
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1493 - S1493
  • [12] PROGNOSTIC IMPACT OF MESENTERIC LYMPH NODE METASTASIS IN PATIENTS WITH ADVANCED OVARIAN CANCER
    Pop, C. F.
    Veys, I.
    El Asmar, A.
    Polastro, L.
    Kerger, J.
    Chintinne, M.
    Larsimont, D.
    Liberale, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A275 - A275
  • [13] Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer
    Akinori Takagane
    Masanori Terashima
    Kaoru Abe
    Munemitsu Araya
    Takashi Irinoda
    Hitoshi Yonezawa
    Tsutomu Nakaya
    Toru Inaba
    Kenichi Oyama
    Hisataka Fujiwara
    Kazuyoshi Saito
    Gastric Cancer, 1999, 2 (2) : 122 - 128
  • [14] The clinical features and prognostic factors for survival in gastric cancer patients with brain metastasis
    Joohan, Lim
    Hee, Lee Moon
    Sun, Park Ji
    Jinhyun, Cho
    ANNALS OF ONCOLOGY, 2017, 28
  • [15] A Prognostic Model to Predict Clinical Outcome in Gastric Cancer Patients with Bone Metastasis
    Park, Hyung Soon
    Rha, Sun Young
    Kim, Hyo Song
    Hyung, Woo Jin
    Park, Ji Soo
    Chung, Hyun Cheol
    Noh, Sung Hoon
    Jeung, Hei-Cheul
    ONCOLOGY, 2011, 80 (1-2) : 142 - 150
  • [16] GASTRIC METASTASIS FROM AN OVARIAN CANCER; A RARE CONDITION
    Ayhan, S.
    Ozdal, B.
    Yalcin, H.
    Sirvan, L.
    Gungor, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [17] Isolated ovarian metastasis of gastric cancer: Krukenberg tumor
    Uyeturk, Ummugul
    Arslan, Serife Hulya
    Bal, Oznur
    Arslan, Ulku Yalcintas
    Oksuzoglu, Omur Berna Cakmak
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (06): : 515 - 519
  • [18] Clinical and pathological study of gastric cancer with ovarian metastasis
    O. Kobayashi
    Y. Sugiyama
    H. Cho
    A. Tsuburaya
    M. Sairenji
    H. Motohashi
    T. Yoshikawa
    International Journal of Clinical Oncology, 2003, 8 (2) : 0067 - 0071
  • [19] Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study
    Prisco, Maria Grazia
    Zannoni, Gian Franco
    De Stefano, Ilaria
    Vellone, Valerio Gaetano
    Tortorella, Lucia
    Fagotti, Anna
    Mereu, Liliana
    Scambia, Giovanni
    Gallo, Daniela
    HUMAN PATHOLOGY, 2012, 43 (02) : 282 - 288
  • [20] Brain metastasis in ovarian cancer patients
    da Costa, A. A. B. A.
    Dos Santos, E. S.
    de Brot, L.
    Ribeiro, A. R. G.
    Cotrim, D. P.
    Carvalho Pandolfi, N.
    Cesca, M. G.
    Chen, M. J.
    Baiocchi, G.
    ANNALS OF ONCOLOGY, 2018, 29